These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37289061)

  • 1.
    Cunningham SA; Rodriguez C; Woerther PL; Menigaux C; Bauer T; Herrmann JL; Rottman M; Roux AL; Gaillard JL; Patel R; El Sayed F
    Microbiol Spectr; 2023 Aug; 11(4):e0368722. PubMed ID: 37289061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant Cutibacterium avidum isolated from patients with acne vulgaris and other infections.
    Koizumi J; Nakase K; Hayashi N; Nasu Y; Hirai Y; Nakaminami H
    J Glob Antimicrob Resist; 2022 Mar; 28():151-157. PubMed ID: 35017069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium)
    Corvec S
    Clin Microbiol Rev; 2018 Jul; 31(3):. PubMed ID: 29848774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention-results from a prospective observational cohort study.
    Tschudin-Sutter S; Frei R; Dangel M; Jakob M; Balmelli C; Schaefer DJ; Weisser M; Elzi L; Battegay M; Widmer AF
    Clin Microbiol Infect; 2016 May; 22(5):457.e1-9. PubMed ID: 26806134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-peritoneal abscess after an abdominal hysterectomy involving Cutibacterium avidum (former Propionibacterium avidum) highly resistant to clindamycin.
    Legaria MC; Barberis C; Camporro J; Traglia GM; Famiglietti A; Stecher D; Vay CA
    Anaerobe; 2019 Oct; 59():176-183. PubMed ID: 31254654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
    Wouthuyzen-Bakker M; Tornero E; Morata L; Nannan Panday PV; Jutte PC; Bori G; Kampinga GA; Soriano A
    Int J Antimicrob Agents; 2018 Jan; 51(1):38-42. PubMed ID: 28668678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Rifampin against Staphylococcal Biofilm Infections
    Zimmerli W; Sendi P
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutibacterium avidum resists surgical skin antisepsis in the groin-a potential risk factor for periprosthetic joint infection: a quality control study.
    Maurer SM; Kursawe L; Rahm S; Prinz J; Zinkernagel AS; Moter A; Kuster SP; Zbinden R; Zingg PO; Achermann Y
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):27. PubMed ID: 33522957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.
    Kang SL; Rybak MJ; McGrath BJ; Kaatz GW; Seo SM
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2702-9. PubMed ID: 7695250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection.
    Meléndez-Carmona MÁ; Muñoz-Gallego I; Viedma E; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2019 Sep; 54(3):356-360. PubMed ID: 31254616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections.
    Kusejko K; Auñón Á; Jost B; Natividad B; Strahm C; Thurnheer C; Pablo-Marcos D; Slama D; Scanferla G; Uckay I; Waldmann I; Esteban J; Lora-Tamayo J; Clauss M; Fernandez-Sampedro M; Wouthuyzen-Bakker M; Ferrari MC; Gassmann N; Sendi P; Jent P; Morand PC; Vijayvargiya P; Trebše R; Patel R; Kouyos RD; Corvec S; Kramer TS; Stadelmann VA; Achermann Y
    Clin Infect Dis; 2021 Jun; 72(12):e1064-e1073. PubMed ID: 33300545
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kong Y; Li C; Li G; Yang T; Draz MS; Xie X; Zhang J; Ruan Z
    Microbiol Spectr; 2022 Jun; 10(3):e0009922. PubMed ID: 35532225
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Karlsson J; Kamenska N; Matuschek E; Brüggemann H; Söderquist B
    Microorganisms; 2024 Feb; 12(3):. PubMed ID: 38543483
    [No Abstract]   [Full Text] [Related]  

  • 14. Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin.
    Meléndez-Carmona MÁ; Mancheño-Losa M; Ruiz-Sorribas A; Muñoz-Gallego I; Viedma E; Chaves F; Van Bambeke F; Lora-Tamayo J
    J Antimicrob Chemother; 2022 Nov; 77(12):3265-3269. PubMed ID: 36124848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
    Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutibacterium (Formerly Propionibacterium) avidum: A Rare but Avid Agent of Prosthetic Hip Infection.
    Zeller VA; Letembet VA; Meyssonnier VA; Heym B; Ziza JM; Marmor SD
    J Arthroplasty; 2018 Jul; 33(7):2246-2250. PubMed ID: 29544969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis of streptococcal prosthetic bone and joint infections depends on surgical management-A multicenter retrospective study.
    Mahieu R; Dubée V; Seegers V; Lemarié C; Ansart S; Bernard L; Le Moal G; Asseray N; Arvieux C; Ramanantsoa C; Cormier H; Legrand E; Abgueguen P;
    Int J Infect Dis; 2019 Aug; 85():175-181. PubMed ID: 31212103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutibacterium avidum is phylogenetically diverse with a subpopulation being adapted to the infant gut.
    Rocha Martin VN; Lacroix C; Killer J; Bunesova V; Voney E; Braegger C; Schwab C
    Syst Appl Microbiol; 2019 Jul; 42(4):506-516. PubMed ID: 31128887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin-Loaded Nanoparticles Decrease Emergence of Fluoroquinolone Resistance in Escherichia coli.
    Hadiya S; Liu X; Abd El-Hammed W; Elsabahy M; Aly SA
    Microb Drug Resist; 2018 Oct; 24(8):1098-1107. PubMed ID: 29431570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.